Stepwise logistic regression and Cox analyses, adjusted for the propensity score
| . | OR (95% CL) . | P-value . |
|---|---|---|
| 30-day mortality | ||
| LV volume reduction | 3.3 (1.3–8.5) | 0.013 |
| MVS | 3.2 (1.2–8.4) | 0.018 |
| Age | 1.06 (1.01–1.12) | 0.031 |
| NYHA class | 3.1 (1.6–6.5) | 0.001 |
| HR (95% CL) | P-value | |
| 10-year any deaths | ||
| LV volume reduction | 1.3 (1.1–2.1) | 0.033 |
| MVS | 2.7 (1.4–3.3) | 0.000 |
| 10-year cardiac deaths | ||
| LV volume reduction | 1.8 (1.2–2.9) | 0.002 |
| MVS | 2.6 (1.7–4.0) | 0.000 |
| 10-year cardiac events | ||
| LV volume reduction | 2.0 (1.4–2.3) | 0.001 |
| MVS | 2.3 (1.6–3.4) | 0.000 |
| 10-year any events | ||
| LV volume reduction | 1.7 (1.1–2.6) | 0.003 |
| MVS | 2.6 (1.8–3.5) | 0.000 |
| . | OR (95% CL) . | P-value . |
|---|---|---|
| 30-day mortality | ||
| LV volume reduction | 3.3 (1.3–8.5) | 0.013 |
| MVS | 3.2 (1.2–8.4) | 0.018 |
| Age | 1.06 (1.01–1.12) | 0.031 |
| NYHA class | 3.1 (1.6–6.5) | 0.001 |
| HR (95% CL) | P-value | |
| 10-year any deaths | ||
| LV volume reduction | 1.3 (1.1–2.1) | 0.033 |
| MVS | 2.7 (1.4–3.3) | 0.000 |
| 10-year cardiac deaths | ||
| LV volume reduction | 1.8 (1.2–2.9) | 0.002 |
| MVS | 2.6 (1.7–4.0) | 0.000 |
| 10-year cardiac events | ||
| LV volume reduction | 2.0 (1.4–2.3) | 0.001 |
| MVS | 2.3 (1.6–3.4) | 0.000 |
| 10-year any events | ||
| LV volume reduction | 1.7 (1.1–2.6) | 0.003 |
| MVS | 2.6 (1.8–3.5) | 0.000 |
LV: left ventricle; MVS: mitral valve surgery; NYHA: New York Heart Association; OR: odds ratio; HR: hazard ratio.
Stepwise logistic regression and Cox analyses, adjusted for the propensity score
| . | OR (95% CL) . | P-value . |
|---|---|---|
| 30-day mortality | ||
| LV volume reduction | 3.3 (1.3–8.5) | 0.013 |
| MVS | 3.2 (1.2–8.4) | 0.018 |
| Age | 1.06 (1.01–1.12) | 0.031 |
| NYHA class | 3.1 (1.6–6.5) | 0.001 |
| HR (95% CL) | P-value | |
| 10-year any deaths | ||
| LV volume reduction | 1.3 (1.1–2.1) | 0.033 |
| MVS | 2.7 (1.4–3.3) | 0.000 |
| 10-year cardiac deaths | ||
| LV volume reduction | 1.8 (1.2–2.9) | 0.002 |
| MVS | 2.6 (1.7–4.0) | 0.000 |
| 10-year cardiac events | ||
| LV volume reduction | 2.0 (1.4–2.3) | 0.001 |
| MVS | 2.3 (1.6–3.4) | 0.000 |
| 10-year any events | ||
| LV volume reduction | 1.7 (1.1–2.6) | 0.003 |
| MVS | 2.6 (1.8–3.5) | 0.000 |
| . | OR (95% CL) . | P-value . |
|---|---|---|
| 30-day mortality | ||
| LV volume reduction | 3.3 (1.3–8.5) | 0.013 |
| MVS | 3.2 (1.2–8.4) | 0.018 |
| Age | 1.06 (1.01–1.12) | 0.031 |
| NYHA class | 3.1 (1.6–6.5) | 0.001 |
| HR (95% CL) | P-value | |
| 10-year any deaths | ||
| LV volume reduction | 1.3 (1.1–2.1) | 0.033 |
| MVS | 2.7 (1.4–3.3) | 0.000 |
| 10-year cardiac deaths | ||
| LV volume reduction | 1.8 (1.2–2.9) | 0.002 |
| MVS | 2.6 (1.7–4.0) | 0.000 |
| 10-year cardiac events | ||
| LV volume reduction | 2.0 (1.4–2.3) | 0.001 |
| MVS | 2.3 (1.6–3.4) | 0.000 |
| 10-year any events | ||
| LV volume reduction | 1.7 (1.1–2.6) | 0.003 |
| MVS | 2.6 (1.8–3.5) | 0.000 |
LV: left ventricle; MVS: mitral valve surgery; NYHA: New York Heart Association; OR: odds ratio; HR: hazard ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
